Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Other Accumulated Expenses (2016 - 2025)

Regenxbio has reported Other Accumulated Expenses over the past 12 years, most recently at $757000.0 for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $757000.0 for Q4 2025, up 16.64% from a year ago — trailing twelve months through Dec 2025 was $757000.0 (up 16.64% YoY), and the annual figure for FY2025 was $757000.0, up 16.64%.
  • Other Accumulated Expenses for Q4 2025 was $757000.0 at Regenxbio, down from $929000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for RGNX hit a ceiling of $999000.0 in Q1 2023 and a floor of $122000.0 in Q1 2021.
  • Median Other Accumulated Expenses over the past 5 years was $748000.0 (2022), compared with a mean of $697500.0.
  • Peak annual rise in Other Accumulated Expenses hit 363.44% in 2021, while the deepest fall reached 58.64% in 2021.
  • Regenxbio's Other Accumulated Expenses stood at $744000.0 in 2021, then increased by 0.27% to $746000.0 in 2022, then plummeted by 38.61% to $458000.0 in 2023, then skyrocketed by 41.7% to $649000.0 in 2024, then increased by 16.64% to $757000.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $757000.0 (Q4 2025), $929000.0 (Q3 2025), and $736000.0 (Q2 2025) per Business Quant data.